ADARB1 and hepatocellular carcinoma: Our results demonstrated that two novel genetic variants (METTL3 rs1263790 and ADARB1 rs57884102) may be potential prognostic markers for HBV‐HCC, but these results need larger different ethnic cohorts and functional experiments to validate in the future.